This effect has been exploited to target anti-PD-L1-functionalized lipid nanoparticles, carrying toxic compounds, to these myeloid cells in conjunction with irradiation, leading to an improved anti-tumor response in mice (Zhang et al., 2019). The gene discussed is CD274; the disease is neoplasm.